382 related articles for article (PubMed ID: 37206081)
1. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review.
Kumar A; Gautam V; Sandhu A; Rawat K; Sharma A; Saha L
World J Gastrointest Surg; 2023 Apr; 15(4):495-519. PubMed ID: 37206081
[TBL] [Abstract][Full Text] [Related]
2. T-cell-based immunotherapy in colorectal cancer.
Feng M; Zhao Z; Yang M; Ji J; Zhu D
Cancer Lett; 2021 Feb; 498():201-209. PubMed ID: 33129958
[TBL] [Abstract][Full Text] [Related]
3. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
4. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer.
Abdellatif AAH; Alshubrumi AS; Younis MA
AAPS PharmSciTech; 2024 Jan; 25(1):23. PubMed ID: 38267656
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis.
Yu X; Zhu L; Liu J; Xie M; Chen J; Li J
Onco Targets Ther; 2020; 13():11645-11658. PubMed ID: 33223838
[TBL] [Abstract][Full Text] [Related]
6. Basics to advances in nanotherapy of colorectal cancer.
Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
Matos AI; Carreira B; Peres C; Moura LIF; Conniot J; Fourniols T; Scomparin A; Martínez-Barriocanal Á; Arango D; Conde JP; Préat V; Satchi-Fainaro R; Florindo HF
J Control Release; 2019 Aug; 307():108-138. PubMed ID: 31226355
[TBL] [Abstract][Full Text] [Related]
8. Triumph against cancer: invading colorectal cancer with nanotechnology.
Vinchhi P; Patel MM
Expert Opin Drug Deliv; 2021 Sep; 18(9):1169-1192. PubMed ID: 33567909
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer.
Effendi-Ys R
Acta Med Indones; 2022 Jul; 54(3):476-486. PubMed ID: 36156476
[TBL] [Abstract][Full Text] [Related]
10. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?
Olguin JE; Mendoza-Rodriguez MG; Sanchez-Barrera CA; Terrazas LI
World J Gastrointest Oncol; 2023 Feb; 15(2):251-267. PubMed ID: 36908325
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches.
Dariya B; Aliya S; Merchant N; Alam A; Nagaraju GP
Crit Rev Oncog; 2020; 25(2):71-94. PubMed ID: 33389859
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer and therapy response: a focus on the main mechanisms involved.
Tirendi S; Marengo B; Domenicotti C; Bassi AM; Almonti V; Vernazza S
Front Oncol; 2023; 13():1208140. PubMed ID: 37538108
[TBL] [Abstract][Full Text] [Related]
13. Molecular Landscape and Therapeutic Strategies against Colorectal Cancer.
Patel A; Gulhati P
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672633
[TBL] [Abstract][Full Text] [Related]
14. A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon.
Yi J; Lin P; Li Q; Zhang A; Kong X
Mol Ther Oncolytics; 2023 Sep; 30():254-274. PubMed ID: 37701850
[TBL] [Abstract][Full Text] [Related]
15. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy.
Nikolouzakis TK; Chrysos E; Docea AO; Fragkiadaki P; Souglakos J; Tsiaoussis J; Tsatsakis A
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893120
[TBL] [Abstract][Full Text] [Related]
16. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer.
Jiang H; Zhou S; Li G
Front Pharmacol; 2023; 14():1189799. PubMed ID: 37719843
[TBL] [Abstract][Full Text] [Related]
17. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanocarriers: A promising tool for early diagnosis and efficient treatment of colorectal cancer.
Haider M; Zaki KZ; El Hamshary MR; Hussain Z; Orive G; Ibrahim HO
J Adv Res; 2022 Jul; 39():237-255. PubMed ID: 35777911
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies.
Clarke CN; Kopetz ES
J Gastrointest Oncol; 2015 Dec; 6(6):660-7. PubMed ID: 26697199
[TBL] [Abstract][Full Text] [Related]
20. Multimodal treatment strategies for colorectal liver metastases.
Birrer DL; Tschuor C; Reiner C; Fritsch R; Pfammatter T; Garcia Schüler H; Pavic M; De Oliveira M; Petrowsky H; Dutkowski P; Oberkofler C; Clavien PA
Swiss Med Wkly; 2021 Feb; 151():w20390. PubMed ID: 33631027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
